Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The rationale for combining BPC-157 and TB-500 is based on the premise that the two peptides may act through complementary mechanisms
For instance, one experiment indicates the anti-RCS potential of GHK-Cu against radicals such as 4-hydroxynonenal, acrolein, and malondialdehyde, among others
Injectable Advantages Injectable GHK-Cu bypasses the skin barrier entirely, delivering the peptide directly to subcutaneous tissue with near 100% bioavailability
Experimental metabolic pathway regulation
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
